Sugen deal

SUGN (Redwood City, Calif.) and Zeneca Group agreed to develop anti-cancer drugs targeting cell surface receptors and intracellular signal transduction pathways.

Zeneca will purchase 789,141

Read the full 255 word article

How to gain access

Continue reading with a
two-week free trial.